Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
International Journal of Molecular Sciences · 04.01.2023 · 24 (2) · 910
DOI: 10.3390/ijms24020910 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.01.2023. Verfasst von Francesco Lasorsa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Urology, Andrology and Kidney Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro"…. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate cancer (PCa) is the most common male malignancy and the fifth leading cause of cancer death in men worldwide. Prostate cancer cells are characterized by a hybrid glycolytic/oxidative phosphorylation phenotype determined by androgen receptor signaling. An increased lipogenesis and cholesterogenesis have been described in PCa cells. Many studies have shown that enzymes involved in these pathways are overexpressed in PCa. Glutamine becomes an essential amino acid for PCa cells, and its metabolism is thought to become an attractive therapeutic target. A crosstalk between cancer and stromal cells occurs in the tumor microenvironment because of the release of different cytokines and growth factors and due to changes in the extracellular matrix. A deeper insight into the metabolic changes may be obtained by a multi-omic approach integrating genomics, transcriptomics, metabolomics, lipidomics, and radiomics data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urology, Andrology and Kidney Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", 70124 Bari, Italy.
- Division of Urology, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
- Department of Translational Medical Sciences, University of Naples "Federico II", 80131 Naples, Italy.
- The Institution Organizing University Doctoral Studies (I.O.S.U.D.), George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, 540142 Târgu Mureș, Romania.
ORCID-Profile: Matteo Ferro, Daniela Terracciano, Octavian Sabin Tataru, Pasquale Ditonno, Giuseppe Lucarelli
Zitieren
APA
Lasorsa, F., di Meo, N. A., Rutigliano, M., Ferro, M., Terracciano, D., Tataru, O. S., Battaglia, M., Ditonno, P., & Lucarelli, G. (2023). Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer. International Journal of Molecular Sciences, 24(2), 910. https://doi.org/10.3390/ijms24020910
Vancouver
Lasorsa F, di Meo NA, Rutigliano M, Ferro M, Terracciano D, Tataru OS, et al. Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer. International Journal of Molecular Sciences. 2023;24(2):910. doi:10.3390/ijms24020910
BibTeX
@article{Lasorsa2023,
author = {Lasorsa, Francesco and di Meo, Nicola Antonio and Rutigliano, Monica and Ferro, Matteo and Terracciano, Daniela and Tataru, Octavian Sabin and Battaglia, Michele and Ditonno, Pasquale and Lucarelli, Giuseppe},
title = {Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {910},
doi = {10.3390/ijms24020910}
}
EUVIMED